Comments on: First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months

Comments on: First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months https://www.worldpharmatoday.com/clinical-trails/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rtss-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/ Magazine for the C-level Pharma Executives Mon, 17 Oct 2011 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4